Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Diagnostics Market (Immunoassays, Clinical Chemistry, Haematology & Coagulation): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering.
European medical diagnostics market is expected to reach US$109.91 billion in 2028, growing at a CAGR of 5.69%, for the time period of 2024-2028
Factors such as rise in number of new cancer cases, expansion of medical device industry, growth in geriatric population, accelerating demand for In-Vitro Diagnostic (IVD) and rapid urbanization would drive the growth of the market.
However the market growth would be challenged by lack of skilled professionals, high cost of infectious diseases diagnosis and stringent government regulations. A few notable trends mat include, emerging role of precision medicine, emergence of various pandemic diseases and demand for point-of-care (POC) tests.
Based on technology, the market has been segmented into immunoassays, clinical chemistry, haematology and coagulation. With the development of signal generation methods, the attention has shifted to the development of immunochemical methods and instruments to provide convenient, high-performance systems. As a result of this, the demand for immunoassays is rising, which is aiding the market growth of medical diagnostics in Europe.
Based on country, the market has been segmented into Germany, the U.K., France and Rest of Europe. Due to the continuous collaboration and partnerships between diagnostics companies, along with the expansion of the healthcare infrastructure, Germany continues to be the dominant country, which is capturing significant share in the medical diagnostics market in Europe.
Scope of the report
- The report provides a comprehensive analysis of the European Medical Diagnostics Market.
- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
- The company profiles of leading players (Labcorp, Quest Diagnostics, Sonic Healthcare, Eurofins Scientific, Synlab and Medicover) are also presented in detail.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 61 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value (USD) in 2024 | $88.1 Billion |
| Forecasted Market Value (USD) by 2028 | $109.91 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Europe |
Key Topics Covered:
1. Overview
1.1 Introduction
1.2 Categories of Lab Testing
1.3 Type of Diagnostic Products
1.4 Common Examples of Diagnostic Tests
1.5 Diagnosis of Infectious Diseases
1.6 Conceptualization of Diagnosis Process
2. Impact of COVID-19
2.1 Increase in COVID-19 Tests
2.2 Growth in Companies COVID-19 Sales
2.3 Demand for COVID-19 Self-test Kits
3. Europe Market Analysis
3.1 Europe Medical Diagnostics Market by Value
3.2 Europe Medical Diagnostics Market Forecast by Value
3.3 Europe Medical Diagnostics Market by Technology
3.3.1 Europe Immunoassays Diagnostics Market by Value
3.3.2 Europe Immunoassays Diagnostics Market Forecast by Value
3.3.3 Europe Clinical Chemistry Diagnostics Market by Value
3.3.4 Europe Clinical Chemistry Diagnostics Market Forecast by Value
3.3.5 Europe Haematology Diagnostics Market by Value
3.3.6 Europe Haematology Diagnostics Market Forecast by Value
3.3.7 Europe Coagulation Diagnostics Market by Value
3.3.8 Europe Coagulation Diagnostics Market Forecast by Value
3.4 Europe Medical Diagnostics Market by Country
3.4.1 Germany Medical Diagnostics Market by Value
3.4.2 Germany Medical Diagnostics Market Forecast by Value
3.4.3 The U.K. Medical Diagnostics Market by Value
3.4.4 The U.K. Medical Diagnostics Market Forecast by Value
3.4.5 France Medical Diagnostics Market by Value
3.4.6 France Medical Diagnostics Market Forecast by Value
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rise in Number of New Cancer Cases
4.1.2 Expansion of Medical Devices Industry
4.1.3 Growth in Geriatric Population
4.1.4 Accelerating Demand for In-Vitro Diagnostic (IVD)
4.1.5 Rapid Urbanization
4.1.6 Growing Awareness About Various Infectious Diseases
4.2 Key Trends and Developments
4.2.1 Emerging Role of Precision Medicine
4.2.2 Emergence of Various Pandemic Diseases
4.2.3 Demand for Point-of-Care (POC) Tests
4.3 Challenges
4.3.1 Lack of Skilled Professionals
4.3.2 High Cost of Infectious Diseases Diagnosis
4.3.3 Stringent Government Regulations
5. Company Profiles
5.1 Labcorp
5.2 Quest Diagnostics
5.3 Sonic Healthcare
5.4 Eurofins Scientific
5.5 Synlab
5.6 Medicover
For more information about this report visit https://www.researchandmarkets.com/r/cuxmrs
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
